Michelandrea De Cesare
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma.
Journal: Cancer gene therapy
Published: December 03, 2021
Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells.
Journal: Biochemical pharmacology
Published: October 21, 2021
Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models.
Journal: Cancers
Published: March 28, 2019
High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts.
Journal: Anticancer research
Published: August 06, 2018
Synthesis and Evaluation of the Tumor Cell Growth Inhibitory Potential of New Putative HSP90 Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: December 30, 2017
Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases.
Journal: Cancer letters
Published: October 17, 2017
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models.
Journal: Biochemical pharmacology
Published: October 05, 2017
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat.
Journal: Hematological oncology
Published: June 28, 2017
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment.
Journal: Journal of medicinal chemistry
Published: March 09, 2017
Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: February 24, 2017
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.
Journal: Journal of hematology & oncology
Published: October 01, 2016
3-Arylidene-N-hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity.
Journal: ChemMedChem
Published: April 27, 2016
Last Updated: 09/26/2026